HSIC:NSD-Henry Schein Inc (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 72.46

Change

+1.22 (+1.71)%

Market Cap

USD 8.92B

Volume

1.58M

Analyst Target

USD 72.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
PDCO Patterson Companies Inc

+0.22 (+1.01%)

USD 1.93B
AHG Akso Health Group ADR

+0.15 (+15.82%)

USD 0.22B
EDAP EDAP TMS SA

-0.07 (-2.22%)

USD 0.12B
YI 111 Inc

-0.05 (-7.69%)

USD 0.05B
COSM Cosmos Health Inc.

-0.03 (-2.63%)

N/A
ZYXI Zynex Inc

-0.01 (-0.12%)

N/A

ETFs Containing HSIC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.29% 86% B+ 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.29% 86% B+ 42% F
Trailing 12 Months  
Capital Gain -2.70% 71% C- 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.70% 71% C- 41% F
Trailing 5 Years  
Capital Gain 15.29% 83% B 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.29% 83% B 53% F
Average Annual (5 Year Horizon)  
Capital Gain 3.93% 57% F 55% F
Dividend Return 3.93% 57% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.10% 100% F 81% B-
Risk Adjusted Return 22.97% 57% F 57% F
Market Capitalization 8.92B 100% F 92% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.